Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Murine Ileitis and Progressive Ileal Crohn's Disease

Bach, 2002, The effect of infections on susceptibility to autoimmune and allergic diseases, N Engl J Med, 347, 911, 10.1056/NEJMra020100 Gaudreau, 2007, Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells, J Immunol, 179, 3638, 10.4049/jimmunol.179.6.3638 Jinushi, 2007, MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF, J Clin Invest, 117, 1902, 10.1172/JCI30966 Rosenbloom, 2005, Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients, Chest, 127, 2139, 10.1378/chest.127.6.2139 Uchida, 2007, GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis, N Engl J Med, 356, 567, 10.1056/NEJMoa062505 Parkes, 2007, Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility, Nat Genet, 39, 830, 10.1038/ng2061 Rioux, 2007, Genome-wide association study identifies new susceptibility loci for Crohn's disease and implicates autophagy in disease pathogenesis, Nat Genet, 39, 596, 10.1038/ng2032 Hugot, 2001, Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, Nature, 411, 599, 10.1038/35079107 Ogura, 2001, A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease, Nature, 411, 603, 10.1038/35079114 Li, 2004, Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations, Hum Mol Genet, 13, 1715, 10.1093/hmg/ddh182 Hugot, 2007, Prevalence of CARD15/NOD2 mutations in Caucasian healthy people, Am J Gastroenterol, 102, 1259, 10.1111/j.1572-0241.2007.01149.x Takeuchi, 2006, Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease, Clin Gastroenterol Hepatol, 4, 196, 10.1016/S1542-3565(05)00980-8 Lodes, 2004, Bacterial flagellin is a dominant antigen in Crohn's disease, J Clin Invest, 113, 1296, 10.1172/JCI200420295 Marks, 2006, Defective acute inflammation in Crohn's disease: a clinical investigation, Lancet, 367, 668, 10.1016/S0140-6736(06)68265-2 Biagioni, 2006, Redox state and O2*- production in neutrophils of Crohn's disease patients, Exp Biol Med (Maywood), 231, 186, 10.1177/153537020623100209 Korzenik, 2005, Sargramostim for active Crohn's disease, N Engl J Med, 352, 2193, 10.1056/NEJMoa041109 Sainathan, 2007, Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis, Inflamm Bowel Dis, 14, 88, 10.1002/ibd.20279 Satsangi, 2006, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, Gut, 55, 749, 10.1136/gut.2005.082909 Uchida, 2004, High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis, Blood, 103, 1089, 10.1182/blood-2003-05-1565 Neimark, 2006, c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter, Gastroenterology, 131, 554, 10.1053/j.gastro.2006.05.002 Dubinsky, 2006, Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression, Am J Gastroenterol, 101, 360, 10.1111/j.1572-0241.2006.00456.x Kugathasan, 2004, CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease, Clin Gastroenterol Hepatol, 2, 1003, 10.1016/S1542-3565(04)00452-5 Hassan, 1988, Phorbol myristate acetate induced oxidation of 2′, 7′-dichlorofluorescin by neutrophils from patients with chronic granulomatous disease, J Leukoc Biol, 43, 317, 10.1002/jlb.43.4.317 Carey, 2008, Activation of an IL-6:STAT3-dependent transcriptome in pediatric-onset inflammatory bowel disease, Inflamm Bowel Dis, 14, 446, 10.1002/ibd.20342 Han, 2004, Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice, Shock, 21, 261, 10.1097/01.shk.0000112346.38599.10 Gupta, 2006, Risk factors for initial surgery in pediatric patients with Crohn's disease, Gastroenterology, 130, 1069, 10.1053/j.gastro.2006.02.003 Watanabe, 2007, Anti-cytokine autoantibodies are ubiquitous in healthy individuals, FEBS Lett, 581, 2017, 10.1016/j.febslet.2007.04.029 Mow, 2004, Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease, Gastroenterology, 126, 414, 10.1053/j.gastro.2003.11.015 Zholudev, 2004, Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype, Am J Gastroenterol, 99, 2235, 10.1111/j.1572-0241.2004.40369.x Korzenik, 2000, Is Crohn's disease an immunodeficiency?, Dig Dis Sci, 45, 1121, 10.1023/A:1005541700805 Harbord, 2006, Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor, Aliment Pharmacol Ther, 24, 651, 10.1111/j.1365-2036.2006.03016.x Catarzi, 2008, Apoptosis and Bax, Bcl-2, Mcl-1 expression in neutrophils of Crohn's disease patients, Inflamm Bowel Dis, 14, 819, 10.1002/ibd.20397 Wittmann, 2004, Cytokine up-regulation of surface antigens correlates to the priming of the neutrophil oxidative burst response, Cytometry A, 57, 53, 10.1002/cyto.a.10108 Bouma, 2003, The immunological and genetic basis of inflammatory bowel disease, Nat Rev Immunol, 3, 521, 10.1038/nri1132